首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名：New england journal of medicine

缩写：NEW ENGL J MED

ISSN：0028-4793

e-ISSN：1533-4406

IF/分区：78.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引35954条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock [0.03%]
Fran Balamuth,Scott L Weiss,Elliot Long et al. Fran Balamuth et al.
Background: Whether treatment with balanced crystalloid fluid leads to better outcomes than 0.9% saline in children treated for septic shock is debated. M...
The New England journal of medicine. 2026 Apr 24:10.1056/NEJMoa2601969. DOI:10.1056/NEJMoa2601969 2026
Measles 2025. Reply [0.03%]
Lien Anh Ha Do,Kim Mulholland Lien Anh Ha Do
Comment The New England journal of medicine. 2026 Apr 23;394(16):1663-1664. DOI:10.1056/NEJMc2601679 2026
Measles 2025 [0.03%]
David N Durrheim,Jon K Andrus David N Durrheim
Comment The New England journal of medicine. 2026 Apr 23;394(16):1662-1663. DOI:10.1056/NEJMc2601679 2026
Measles 2025 [0.03%]
Luiz A Bacheschi,Ricardo Nitrini Luiz A Bacheschi
Comment The New England journal of medicine. 2026 Apr 23;394(16):1662. DOI:10.1056/NEJMc2601679 2026
Enzalutamide in Biochemically Recurrent Prostate Cancer. Reply [0.03%]
Neal D Shore,Stephen J Freedland Neal D Shore
Comment The New England journal of medicine. 2026 Apr 23;394(16):1661-1662. DOI:10.1056/NEJMc2602955 2026
Enzalutamide in Biochemically Recurrent Prostate Cancer [0.03%]
Xiaowei Zhang,Ming Zhou,Peiqing Zhao Xiaowei Zhang
Comment The New England journal of medicine. 2026 Apr 23;394(16):1661. DOI:10.1056/NEJMc2602955 2026
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction. Reply [0.03%]
Borja Ibanez,Tomas Jernberg,Dan Atar Borja Ibanez
Comment The New England journal of medicine. 2026 Apr 23;394(16):1660-1661. DOI:10.1056/NEJMc2602963 2026
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction [0.03%]
Elmir Omerovic Elmir Omerovic
Comment The New England journal of medicine. 2026 Apr 23;394(16):1660. DOI:10.1056/NEJMc2602963 2026
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction [0.03%]
Ricky Turgeon Ricky Turgeon
Comment The New England journal of medicine. 2026 Apr 23;394(16):1659-1660. DOI:10.1056/NEJMc2602963 2026
Evolocumab for Primary Prevention of Cardiovascular Disease. Reply [0.03%]
Erin A Bohula,Robert P Giugliano,Marc S Sabatine Erin A Bohula
Comment The New England journal of medicine. 2026 Apr 23;394(16):1658-1659. DOI:10.1056/NEJMc2602103 2026